De Cecco, Marco
Ito, Takahiro
Petrashen, Anna P.
Elias, Amy E.
Skvir, Nicholas J.
Criscione, Steven W.
Caligiana, Alberto
Brocculi, Greta
Adney, Emily M.
Boeke, Jef D.
Le, Oanh
Beauséjour, Christian
Ambati, Jayakrishna
Ambati, Kameshwari
Simon, Matthew
Seluanov, Andrei
Gorbunova, Vera
Slagboom, P. Eline
Helfand, Stephen L.
Neretti, Nicola
Sedivy, John M.
Article History
Received: 20 December 2016
Accepted: 2 November 2018
First Online: 6 February 2019
Change Date: 12 July 2019
Change Type: Correction
Change Details: An Amendment to this paper has been published and can be accessed via a link at the top of the paper.
Competing interests
: J.A. is a cofounder of iVeena Holdings, iVeena Delivery Systems, and Inflammasome Therapeutics, and has been a consultant for Allergan, Biogen, Boehringer-Ingelheim, Janssen, Olix Pharmaceuticals, and Saksin LifeSciences in a capacity unrelated to this work. J.A. and K.A. are named as inventors on patent applications on macular degeneration filed by the University of Kentucky or the University of Virginia. J.D.B. is a founder and Director of Neochromosome, Inc., the Center of Excellence for Engineering Biology, and CDI Labs, Inc. He serves on the Scientific Advisory Boards of Modern Meadow, Inc., Recombinetics, Inc., and Sample6, Inc.